ABSTRACT
bridge to definitive surgery. Advantages of preoperative stent placement also include an elective laparoscopic resection of the tumor as well as the ability to perform a full colonoscopy preoperatively to exclude any synchronous lesions.
Utilization of self-expanding metal stents (SEMS) in the colon was first reported in 1991, [2] and one year later, Spinelli and colleagues [3] reported the placement of a modified GianturcoRosch stent to relieve an acute colonic obstruction secondary to cancer. Although endoscopic alleviation of colorectal obstruction has been used increasingly in recent years, it has not yet become a standard treatment option.
In the present study, we aimed to evaluate the technical and clinical efficacy, safety and clinical outcomes of SEMS for the relief of acute colorectal obstruction secondary to cancer.
MATERIALS AND METHODS
From March 2006 to December 2012, 100 patients with a mean age of 66 years (range, 32-88 years) admitted due to acute colorectal obstruction secondary to cancer were treated
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INTRODUCTION
Acute mechanical intestinal obstruction secondary to colorectal cancer is one of the most common surgical emergencies, usually affecting the left colon. In patients with this condition, emergency surgery is associated with significantly increased morbidity and mortality, as well as ostomy rates. [1] Since the introduction of colonic stenting, the endoscopic approach has been advocated as an alternative to traditional surgery for relieving acute colorectal obstruction, whether palliative or as a in our emergency surgery service. Acute colorectal obstruction was diagnosed as follows: absence of any flatus or bowel movements in the preceding 24 hours, abdominal distention, fecaloid vomiting, and the presence of dilated colonic loops on abdominal radiograph. All patients underwent a routine workup employed for acute mechanical intestinal obstruction (physical exam, blood tests, abdominal X-ray, and computed tomography [CT] scan or magnetic resonance imaging [MRI] ). The rectal cancers were grouped into upper (8-15 cm) and lower (0-7 cm) rectum based on the distance from the anal verge. Colonoscopy with biopsy was performed after hemodynamic stabilization of the patient. In all patients, uncovered self-expanding, through-the-scope metal stents were inserted endoscopically under endoscopic and fluoroscopic monitoring within 24 hours of admission.
Prior to the stent placement, the colon or rectum was cleansed per enema below the stricture. All stenting procedures were performed in the left lateral decubitus position. All patients were premedicated with 2-4 mg intravenous (IV) midazolam and 25-50 mg pethidine hydrochloride before the procedure. To estimate the length, proximal extension, and diameter of the stricture, a water-soluble contrast agent was injected. Under fluoroscopic guidance, a SEMS (Changzhou Zhiye Medical ® China), 6-12 cm in length and 22 mm in diameter, was inserted through the colonoscope. All patients underwent abdominal radiographs to verify the position of the stent as well as to rule out free air. In cases of free peritoneal air, emergency laparotomy was undertaken.
After staging, all patients were evaluated with total colonoscopy passing through the stent to rule out any synchronous lesions. Technical success was defined as successful placement and deployment of the SEMS. Clinical success was considered as colonic decompression within 48 hours without additional endoscopic or surgical intervention following a technically successful SEMS insertion. Antibiotic prophylaxis was applied either with cefuroxime axetil plus metronidazole or ampicillinsulbactam, because inflation of the colon with air during the procedure risks promoting perforation and/or bacteremia. After obtaining adequate decompression of the colon (in cases when staging necessitated a neoadjuvant treatment, following chemoradiotherapy), patients underwent elective open or laparoscopic resection.
A retrospective review of the prospectively compiled patient database was conducted to determine the effectiveness of the procedure, as well as short-and long-term complications. The complications and success rates of the two study groups were compared using Pearson's chi-square or Fisher's exact test as appropriate for categorical variables. Statistical significance was set as p<0.05. The Statistical Package for the Social Sciences (SPSS) V16.0 was used for the statistical analyses.
RESULTS
Stent placement was attempted in 42 of 100 patients. Twenty-six patients underwent SEMS insertion for palliation and 16 patients as a bridging to surgery.
The location of obstruction was observed as the left colon in 2 patients, sigmoid colon in 3 patients, recto-sigmoid junction in 9 patients, upper rectum in 16 patients, and lower rectum (Fig. 1 ). There were no significant differences in complications and success rates when the palliation group was compared with the bridging-to-surgery group (p>0.05) ( Table 1) .
Through-the-stent colonoscopy revealed right colon and transverse colon polyps in 2 patients, who subsequently underwent an endoscopic polypectomy. Sixteen patients, for whom bridging to surgery proved successful later, underwent an elective surgical resection (Table 2) (Fig. 2) , while for 26 patients who had metastatic disease or comorbidity, stent placement was palliative. Tenesmus was the most common complication, noted in 3 (7%) patients, and resolved within 10 days (8-12 days). Distal stent migration occurred in 2 of 42 (4%) cases in whom a technically successful insertion had been achieved. Both of the migrations occurred within the same day of stent placement (1 patient with extrinsic compression and 1 patient with distal rectal cancer). Stent replacement was unsuccessful, and these 2 patients underwent sigmoid loop colostomy for re-obstruction. Rectal bleeding, observed in 2 of 42 patients (4%), stopped spontaneously, and neither blood transfusion nor any other treatment was required.
Insertion-related immediate perforation occurred in 2 patients at the recto-sigmoid junction, whereas no delayed perforation was observed. These patients underwent subtotal colectomy with ileorectal anastomosis. Stent obstruction due to fecal impaction was encountered in 1 case.
DISCUSSION
Approximately 30% of patients with primary colorectal cancer present with subtotal or complete bowel obstruction, which may lead from nausea and vomiting to bowel rupture and finally to death should the condition remain untreated. [4, 5] A number of surgical techniques are available: intraoperative lavage with resection of the involved colonic segment followed by primary anastomosis; subtotal colectomy followed by primary anastomosis; decompressive colostomy followed by resection; and resection of the involved colonic segment followed by end colostomy (Hartmann's operation), ultimately requiring another operation to constitute the gastrointestinal continuity. However, permanent ostomy creation undertaken under emergency conditions is associated with high morbidity rates. The alteration of an acute mechanical colonic obstruction requiring prompt surgical intervention into a semi-elective decompressed state that allows bowel preparation and one-stage definitive oncologic colorectal resection renders this initial endoscopic approach most appealing.
Self-expanding metal stents (SEMS) are placed for several indications in patients with obstructive colorectal malignancies. Advantages of preoperative stent placement include laparoscopic resection of the tumor as well as the ability to perform an elective preoperative colonoscopy to exclude synchronous lesions. On the other hand, following relief of the obstruction with SEMS, the patient can be adequately staged and offered neoadjuvant chemoradiotherapy -whenever indicated-and eventually undergo an elective or semi-elective one-stage colorectal resection. Additionally, stents can be used for palliation of inoperable obstructive colorectal malignancies or extrinsic compression.
Ulus (a) (b) The feasibility, safety, and efficacy of SEMS were evaluated by various retrospective studies. Technical and clinical success rates of SEMS insertion are reported as 94% and 91%, respectively, with negligible SEMS-related mortality. [6] [7] [8] [9] According to these studies, colonic stent placement was found to be a relatively safe technique with a high success rate. In the present study, technical and clinical success rates of SEMS insertion were comparable to those reported in the literature, at 92.8% and 90.4%, respectively.
Colorectal perforation is one of the most common and feared complications of SEMS placement. The greatest risk of perforation is in the recto-sigmoid area, especially at the rectosigmoid junction. A higher probability of perforation appears to confront patients who have had balloon pre-dilation; thus, prior stricture dilation is not recommended. [6] [7] [8] [9] Bevacizumab has also been reported to put patients at significant risk for perforation. Stenting is best avoided, if possible, in patients who are candidates for bevacizumab therapy. [10] In this study, even though balloon dilation was performed on four patients before stent placement, two perforations occurred. These patients had a sharp angulation at the perforation site. Following these events, we abandoned the practice of performing balloon dilation prior to stent insertion.
Stent migrations tend to occur with size-mismatched stents (either too narrow or short in relation to the obstructing lesion) and in the presence of a non-obstructive stricture or of tumor shrinkage following neoadjuvant therapy. In a systematic review evaluating the efficacy and safety of colorectal stents, migration was found to be notably more frequent after laser debulking or chemotherapy, as well as in patients with strictures of benign etiology. [7] In this study, distal stent migration was reported in two (5%) patients, one with extrinsic compression and the other with a lower rectum tumor (0-7 cm), and both occurred within 24 hours. In our experience, stenting should be avoided in patients with a distal rectal tumor up to 2 cm from the anal canal.
Extrinsic compression from pelvic malignancies and lymphadenopathy causing obstruction may also be palliated with stents. [11] However, stenting of extracolonic malignancy is clinically less successful (20%) when compared to colorectal malignancy. Complication rates (33.3%) are markedly increased, and surgical diversion is required more frequently. [12] In the present series, SEMS was used in one patient for palliation of gastric cancer metastasis to the pelvis. In this patient, stent migration occurred and stent replacement was unsuccessful. Due to the relatively small sample size of this study, we were unable to clarify the difference in overall complication rates between intrinsic and extrinsic lesions.
There are a number of reported absolute contraindications to colorectal stenting: (1) clinical or radiological evidence of perforation, and (2) distal rectal cancer (0-5 cm from anal verge), where stenting is likely to cause intense anal pain and/ or fecal incontinence. Relative contraindications include challenging colorectal anatomy (i.e. long strictures, tortuous colonic segments) and colonic ischemia. [13] [14] [15] Laparoscopy is generally contraindicated in the presence of bowel obstruction since a distended bowel precludes a safe access to the abdominal cavity as well as manipulation of the bowel segments. Conversion of an emergent colonic resection into an elective one permits bowel preparation and may potentially avoid an ostomy. Following successful endoscopic stenting of acute colorectal obstruction secondary to cancer, laparoscopic resection may be performed safely with wellknown short-term advantages. An endoluminal stent per se does not necessarily preclude a laparoscopic approach. [16] [17] [18] [19] [20] In this study, laparoscopic resection was technically feasible and comparable to elective colorectal operations, and the presence of a colorectal stent did not affect the laparoscopic approach; 11 patients underwent a successful laparoscopic colorectal resection. SEMS may also provide long-term symptom relief for benign colorectal strictures secondary to diverticular disease, radiotherapy, inflammation, or Crohn's disease, should these patients be deemed medically unfit to undergo a major abdominal operation. [21] [22] [23] Benign stricture was not evaluated in the present study.
In conclusion, stenting of acute mechanical colonic obstruction is an effective option for patients presenting with obstructive colorectal cancer, in which decompression is required to perform an elective one-stage oncologic surgical resection. This approach may also offer palliation for patients who are not candidates for operative intervention, and it is associated with a lower mortality, shorter hospital stay, and decreased stoma creation.
